rs10500127

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBS1BS2

The NM_001164665.2(KIAA1549):​c.187+27403G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00991 in 152,188 control chromosomes in the GnomAD database, including 16 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.0099 ( 16 hom., cov: 33)

Consequence

KIAA1549
NM_001164665.2 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.0420

Publications

0 publications found
Variant links:
Genes affected
KIAA1549 (HGNC:22219): (KIAA1549) The protein encoded by this gene belongs to the UPF0606 family. This gene has been found to be fused to the BRAF oncogene in many cases of pilocytic astrocytoma. The fusion results from 2Mb tandem duplications at 7q34. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2012]
KIAA1549 Gene-Disease associations (from GenCC):
  • retinitis pigmentosa 86
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • retinitis pigmentosa
    Inheritance: AD, AR Classification: SUPPORTIVE, LIMITED Submitted by: Orphanet, G2P

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_001164665.2, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00991 (1508/152188) while in subpopulation NFE AF = 0.0152 (1036/68000). AF 95% confidence interval is 0.0145. There are 16 homozygotes in GnomAd4. There are 661 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 16 AR,AD gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001164665.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KIAA1549
NM_001164665.2
MANE Select
c.187+27403G>T
intron
N/ANP_001158137.1Q9HCM3-1
KIAA1549
NM_020910.3
c.187+27403G>T
intron
N/ANP_065961.2Q9HCM3-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KIAA1549
ENST00000422774.2
TSL:1 MANE Select
c.187+27403G>T
intron
N/AENSP00000416040.2Q9HCM3-1
KIAA1549
ENST00000440172.5
TSL:1
c.187+27403G>T
intron
N/AENSP00000406661.1Q9HCM3-2
KIAA1549
ENST00000924635.1
c.187+27403G>T
intron
N/AENSP00000594694.1

Frequencies

GnomAD3 genomes
AF:
0.00992
AC:
1508
AN:
152068
Hom.:
16
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00307
Gnomad AMI
AF:
0.00220
Gnomad AMR
AF:
0.0141
Gnomad ASJ
AF:
0.00923
Gnomad EAS
AF:
0.000385
Gnomad SAS
AF:
0.00414
Gnomad FIN
AF:
0.00312
Gnomad MID
AF:
0.0287
Gnomad NFE
AF:
0.0152
Gnomad OTH
AF:
0.0148
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.00991
AC:
1508
AN:
152188
Hom.:
16
Cov.:
33
AF XY:
0.00888
AC XY:
661
AN XY:
74418
show subpopulations
African (AFR)
AF:
0.00306
AC:
127
AN:
41528
American (AMR)
AF:
0.0141
AC:
215
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.00923
AC:
32
AN:
3468
East Asian (EAS)
AF:
0.000386
AC:
2
AN:
5186
South Asian (SAS)
AF:
0.00414
AC:
20
AN:
4828
European-Finnish (FIN)
AF:
0.00312
AC:
33
AN:
10582
Middle Eastern (MID)
AF:
0.0340
AC:
10
AN:
294
European-Non Finnish (NFE)
AF:
0.0152
AC:
1036
AN:
68000
Other (OTH)
AF:
0.0147
AC:
31
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
76
152
227
303
379
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00175
Hom.:
0
Bravo
AF:
0.0112
Asia WGS
AF:
0.00231
AC:
8
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
4.7
DANN
Benign
0.63
PhyloP100
-0.042
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs10500127;
hg19: chr7-138638426;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.